Research News

Biosimilar epoetin for cancer and chemotherapy-induced anaemia in the US

Published in: Volume 10 / Year 2021 / Issue 3
Page: 122

Biosimilars are biological drug products that are highly similar to reference products in analytic features, pharmacokinetics and pharmacodynamics, immunogenicity, safety and efficacy. Biosimilar epoetin received US Food and Drug Administration… Read More »

Poor traceability of biologicals in UK ADR reporting indicates the need for improvements to ensure patient safety

Published in: Volume 9 / Year 2020 / Issue 2
Author(s):
Page: 75

Submitted: 27 January 2020; Revised: 29 January 2020; Accepted: 29 January 2020; Published online first: 25 February 2020 Biological medical products (biologicals) are derived from living cells or organisms. Due to… Read More »

HIV patients will accept generic treatments

Published in: Volume 6 / Year 2017 / Issue 4
Author(s):
Page: 164

Human immunodeficiency virus (HIV) patients in high-income countries are likely to accept the introduction of generic antiretroviral (ARV) drugs, according to a study carried out by researchers in Ireland [1].… Read More »

Healthcare professionals will accept generic HIV treatments

Published in: Volume 6 / Year 2017 / Issue 3
Author(s):
Page: 148

Healthcare professionals working with HIV patients in high-income countries are likely to accept the introduction of generic antiretroviral drugs (ARVs), according to a study carried out by researchers in Ireland… Read More »

Go Back Print